PubMed · 1991 · 106 citations · 22 references
MedicineGeneticsMolecular BiologyCancer GeneticsMolecular OncologyNeoplasiaCervical CancerCervical PathologyEndometrial CancerHuman Papillomavirus InfectionOncogenic VirusesSquamous Cell CarcinomaAmino Acid Sequence EffectsE6 ExpressionP53 InactivationP53 MutationTumor Suppressor Gene LossTumor Suppressor Gene MutationsTumor Suppressor P53
The inactivation of the tumor suppressor gene p53 has been demonstrated in a variety of human tumors. In this study, we present a p53 gene analysis of 13 uterine carcinoma cell lines. Sequencing analysis of the entire coding region revealed mutations changing the p53 amino acid composition in all six endometrial carcinoma cell lines tested (Ishikawa, Hecl-A, Hecl-B, KLE, RL95-2, and AN-3). Of the seven cervical carcinoma cell lines, two (HT-3 and C-33A) contained p53 codon changes as well. We were unable to detect human papillomavirus in these two cell lines. By contrast, five human papillomavirus-positive cervical carcinoma cell lines (HeLa S-3, Caski, SiHa, C-4I, and ME-180) contained wild-type p53 gene sequences. We suggest that, in the human papillomavirus-positive cervical tumors, p53 inactivation occurred via the known mechanism of viral E6/cellular p53 protein association, whereas in all other tumors p53 function was compromised by changes in the amino acid sequence.
22
Mutations in the p53 gene occur in diverse human tumour types
Janice Nigro, Suzanne J. Baker, Antonette C. Preisinger et al. · Nature · 1989 · 2.8K citations · Full text
p53: A Frequent Target for Genetic Abnormalities in Lung Cancer
Takashi Takahashi, Marion M. Nau, Itsuo Chiba et al. · Science · 1989 · 1.2K citations